Janus Henderson Group
NUVB icon

Janus Henderson Group’s Nuvation Bio NUVB Stock Holding History

Janus Henderson Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$463K Hold
108,400
– – ﹤0.01% 2037
2025
Q4 		$972K Buy
108,400
+31,700
+41% +$196K ﹤0.01% 1686
2025
Q3 		$283K Hold
76,700
– – ﹤0.01% 2230
2025
Q2 		$150K Hold
76,700
– – ﹤0.01% 2369
2025
Q1 		$139K Hold
76,700
– – ﹤0.01% 2429
2024
Q4 		$204K Hold
76,700
– – ﹤0.01% 2422
2024
Q3 		$176K Hold
76,700
– – ﹤0.01% 2460
2024
Q2 		$224K Buy
+76,700
New +$234K ﹤0.01% 2353
2023
Q4 		– Sell
-51,417
Closed -$69.7K – 2590
2023
Q3 		$69.7K Buy
51,417
+7
+0% +$12 ﹤0.01% 2542
2023
Q2 		$92.3K Sell
51,410
-87
-0.2% -$148 ﹤0.01% 2573
2023
Q1 		$84.7K Buy
51,497
+27,122
+111% +$55K ﹤0.01% 2630
2022
Q4 		$46.7K Sell
24,375
-24,373
-50% -$49.3K ﹤0.01% 2420
2022
Q3 		$110K Buy
48,748
+24,011
+97% +$68.6K ﹤0.01% 2479
2022
Q2 		$80K Buy
24,737
+519
+2% +$2.26K ﹤0.01% 2506
2022
Q1 		$127K Buy
+24,218
New +$136K ﹤0.01% 2528

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group's NUVB Position: Q1 2026 in Review

Janus Henderson Group held its Nuvation Bio (NUVB) position steady in Q1 2026 at 108,400 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #2037.

Janus Henderson Group first reported a position in NUVB in Q1 2022 and has held it in 15 quarters since. The position peaked at $972K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Janus Henderson Group held 108,400 shares of Nuvation Bio worth $463K as of Q1 2026.
  • Janus Henderson Group left its Nuvation Bio share count unchanged in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2037 holding.
  • Janus Henderson Group first reported a position in Nuvation Bio in Q1 2022 and has held it in 15 quarters since.
  • Janus Henderson Group's Nuvation Bio position peaked at $972K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.